• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不丹胃癌高发地区幽门螺杆菌感染及胃黏膜萎缩的血清流行率。

Seroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancer.

机构信息

Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu, Japan.

GI and Liver Center, Bangkok Medical Center, Bangkok, Thailand.

出版信息

J Med Microbiol. 2013 Oct;62(Pt 10):1571-1578. doi: 10.1099/jmm.0.060905-0. Epub 2013 Jul 5.

DOI:10.1099/jmm.0.060905-0
PMID:23831768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3799224/
Abstract

Gastric cancer is the second leading cause of cancer-related mortality in the world. Recently, serum Helicobacter pylori antibodies and pepsinogen (PG) have been used for gastric cancer screening. The incidence of gastric cancer in Bhutan is reported to be quite high compared with that in neighbouring countries. In this study, 381 subjects from three areas of Bhutan were assessed for gastric mucosal atrophy and serological parameters. Anti-H. pylori IgG, PG I, PG II and cytotoxin-associated gene A (CagA) antibodies were measured using ELISA. Subjects were classified into four groups according to H. pylori and PG seropositivity: Group A (H. pylori-negative/PG-negative), Group B (H. pylori-positive/PG-negative), Group C (H. pylori-positive/PG-positive) and Group D (H. pylori-negative/PG-positive). The prevalence of H. pylori in the 381 subjects was 71.1% (271/381), with high infection rates found in rural areas. The PG I/II ratio was significantly inversely correlated with the atrophy score in the antrum and the corpus (P<0.001). Multivariate analysis showed that the PG status was significantly associated with the presence of atrophy in the corpus. The prevalence of the PG-positive status was significantly higher among H. pylori-positive subjects than among H. pylori-negative subjects (P<0.001). Based on the ABC method, Group B was the most dominant, followed by Group A, Group C and Group D. The high incidence of gastric cancer in Bhutan can be attributed to the high prevalence of H. pylori infection and gastric mucosal atrophy.

摘要

胃癌是全球癌症相关死亡的第二大主要原因。最近,血清幽门螺杆菌抗体和胃蛋白酶原(PG)已被用于胃癌筛查。与邻国相比,不丹的胃癌发病率据报道相当高。在这项研究中,对不丹三个地区的 381 名受试者进行了胃黏膜萎缩和血清学参数评估。使用 ELISA 测量抗幽门螺杆菌 IgG、PG I、PG II 和细胞毒素相关基因 A(CagA)抗体。根据 H. pylori 和 PG 血清阳性情况,将受试者分为四组:A 组(H. pylori 阴性/PG 阴性)、B 组(H. pylori 阳性/PG 阴性)、C 组(H. pylori 阳性/PG 阳性)和 D 组(H. pylori 阴性/PG 阳性)。381 名受试者中 H. pylori 的患病率为 71.1%(271/381),农村地区的感染率较高。PG I/II 比值与胃窦和胃体的萎缩评分呈显著负相关(P<0.001)。多变量分析显示,PG 状态与胃体萎缩的存在显著相关。H. pylori 阳性受试者的 PG 阳性状态患病率显著高于 H. pylori 阴性受试者(P<0.001)。根据 ABC 法,B 组最为常见,其次是 A 组、C 组和 D 组。不丹胃癌发病率高的原因可能是 H. pylori 感染和胃黏膜萎缩的高患病率。

相似文献

1
Seroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancer.不丹胃癌高发地区幽门螺杆菌感染及胃黏膜萎缩的血清流行率。
J Med Microbiol. 2013 Oct;62(Pt 10):1571-1578. doi: 10.1099/jmm.0.060905-0. Epub 2013 Jul 5.
2
Helicobacter pylori Infection and Gastric Mucosal Atrophy in Two Ethnic Groups in Nepal.尼泊尔两个族群中的幽门螺杆菌感染与胃黏膜萎缩
Asian Pac J Cancer Prev. 2015;16(17):7911-6. doi: 10.7314/apjcp.2015.16.17.7911.
3
Serum pepsinogen values and Helicobacter pylori status among control subjects of a nested case-control study in the JACC study.日本动脉粥样硬化性心血管疾病(JACC)研究中一项巢式病例对照研究的对照受试者的血清胃蛋白酶原值及幽门螺杆菌感染状况
J Epidemiol. 2005 Jun;15 Suppl 2(Suppl II):S126-33. doi: 10.2188/jea.15.s126.
4
Epidemiology of Helicobacter pylori in Bhutan: the role of environment and Geographic location.不丹幽门螺杆菌的流行病学:环境和地理位置的作用。
Helicobacter. 2014 Feb;19(1):69-73. doi: 10.1111/hel.12088. Epub 2013 Sep 17.
5
Fasting gastric pH of Japanese subjects stratified by IgG concentration against Helicobacter pylori and pepsinogen status.日本受试者的空腹胃液 pH 值按 IgG 浓度对幽门螺杆菌和胃蛋白酶原状态进行分层。
Helicobacter. 2011 Dec;16(6):427-33. doi: 10.1111/j.1523-5378.2011.00868.x.
6
Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics.日本医院患者中幽门螺杆菌感染阴性的胃癌:发病率及病理特征
Cancer Sci. 2007 Jun;98(6):790-4. doi: 10.1111/j.1349-7006.2007.00478.x.
7
The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.中国组织学胃炎分期-“OLGA/OLGIM”与血清胃蛋白酶原检测在评估胃萎缩/肠化生中的相关性
Scand J Gastroenterol. 2017 Aug;52(8):822-827. doi: 10.1080/00365521.2017.1315739. Epub 2017 Apr 22.
8
Epidemiology of Helicobacter pylori infection in asymptomatic schoolchildren in Bhutan.不丹无症状学龄儿童中幽门螺杆菌感染的流行病学。
Helicobacter. 2017 Dec;22(6). doi: 10.1111/hel.12439. Epub 2017 Sep 22.
9
Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.血浆胃饥饿素浓度与血清胃蛋白酶原I水平及胃蛋白酶原I/II比值相关——一种可能的新型非侵入性胃萎缩标志物。
Hepatogastroenterology. 2004 Sep-Oct;51(59):1249-54.
10
Relationship between ghrelin, and gastric mucosal atrophy in hemodialysis patients.血液透析患者中胃饥饿素与胃黏膜萎缩的关系。
World J Gastroenterol. 2016 Dec 21;22(47):10440-10449. doi: 10.3748/wjg.v22.i47.10440.

引用本文的文献

1
Population-level cancer screening and cancer care in Bhutan, 2020-2023: a review.不丹2020 - 2023年的人群层面癌症筛查与癌症护理:综述
Lancet Reg Health Southeast Asia. 2024 Feb 28;24:100370. doi: 10.1016/j.lansea.2024.100370. eCollection 2024 May.
2
Serum pepsinogen level as a biomarker for atrophy, reflux esophagitis, and gastric cancer screening in Indonesia.血清胃蛋白酶原水平作为印度尼西亚萎缩、反流性食管炎和胃癌筛查的生物标志物。
J Res Med Sci. 2022 Dec 23;27:90. doi: 10.4103/jrms.jrms_983_21. eCollection 2022.
3
Stomach Cancer Screening Services of Bhutan.不丹的胃癌筛查服务
Indian J Surg. 2022 Jul 23:1-6. doi: 10.1007/s12262-022-03519-9.
4
A Predictive Model of Noncardia Gastric Adenocarcinoma Risk Using Antibody Response to Helicobacter pylori Proteins and Pepsinogen.基于抗幽门螺杆菌蛋白和胃蛋白酶原抗体反应的非贲门胃腺癌风险预测模型。
Cancer Epidemiol Biomarkers Prev. 2022 Apr 1;31(4):811-820. doi: 10.1158/1055-9965.EPI-21-0869.
5
Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.血清胃蛋白酶原作为南亚和东南亚人群胃癌和胃炎的生物标志物。
PLoS One. 2020 Apr 9;15(4):e0230064. doi: 10.1371/journal.pone.0230064. eCollection 2020.
6
New observations regarding Helicobacter pylori and gastric cancer in Mongolia.蒙古幽门螺杆菌与胃癌的新观察。
Helicobacter. 2018 Aug;23(4):e12491. doi: 10.1111/hel.12491. Epub 2018 Jun 8.
7
Gastric mucosal status in populations with a low prevalence of Helicobacter pylori in Indonesia.印度尼西亚幽门螺杆菌低感染率人群的胃黏膜状况
PLoS One. 2017 May 2;12(5):e0176203. doi: 10.1371/journal.pone.0176203. eCollection 2017.
8
Rare Helicobacter pylori Virulence Genotypes in Bhutan.不丹罕见的幽门螺杆菌毒力基因型
Sci Rep. 2016 Mar 2;6:22584. doi: 10.1038/srep22584.
9
Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation.用于流行病学研究的幽门螺杆菌感染诊断方法:间接检测验证的关键重要性。
Biomed Res Int. 2016;2016:4819423. doi: 10.1155/2016/4819423. Epub 2016 Jan 19.
10
Geographical distribution of the incidence of gastric cancer in Bhutan.不丹胃癌发病率的地理分布。
World J Gastroenterol. 2015 Oct 14;21(38):10883-9. doi: 10.3748/wjg.v21.i38.10883.

本文引用的文献

1
Extremely high prevalence of Helicobacter pylori infection in Bhutan.不丹幽门螺杆菌感染极高。
World J Gastroenterol. 2013 May 14;19(18):2806-10. doi: 10.3748/wjg.v19.i18.2806.
2
Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007-2011.2007-2011 年印度、巴基斯坦和不丹淋病奈瑟菌分离株的药敏性和遗传特征。
BMC Infect Dis. 2013 Jan 24;13:35. doi: 10.1186/1471-2334-13-35.
3
Comparative evaluation of 29 commercial Helicobacter pylori serological kits.29 种商用幽门螺杆菌血清学试剂盒的比较评估。
Helicobacter. 2013 Jun;18(3):169-79. doi: 10.1111/hel.12030. Epub 2013 Jan 14.
4
Serological assessment of gastric mucosal atrophy in gastric cancer.胃癌患者胃黏膜萎缩的血清学评估。
BMC Gastroenterol. 2012 Jan 31;12:10. doi: 10.1186/1471-230X-12-10.
5
Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities.美国成年人中幽门螺杆菌血清阳性率的长期趋势:持续存在的种族/民族差异的证据。
Am J Epidemiol. 2012 Jan 1;175(1):54-9. doi: 10.1093/aje/kwr288. Epub 2011 Nov 15.
6
Epidemiology of Helicobacter pylori infection and public health implications.幽门螺杆菌感染的流行病学和公共卫生意义。
Helicobacter. 2011 Sep;16 Suppl 1(0 1):1-9. doi: 10.1111/j.1523-5378.2011.00874.x.
7
Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".血清抗幽门螺杆菌 IgG 抗体和胃蛋白酶原水平联合检测用于胃癌筛查——“ABC 法”。
Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(7):405-14. doi: 10.2183/pjab.87.405.
8
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
9
Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries.血清幽门螺杆菌 CagA 抗体作为东亚国家胃癌的生物标志物。
Future Microbiol. 2010 Dec;5(12):1885-93. doi: 10.2217/fmb.10.135.
10
The role of serum pepsinogen in the detection of gastric cancer.血清胃蛋白酶原在胃癌检测中的作用。
Gut Liver. 2010 Sep;4(3):307-19. doi: 10.5009/gnl.2010.4.3.307. Epub 2010 Sep 24.